 KEPPRA
|
GlaxoSmithKline Biopharma
|
| levetiracetam |
Antiepiléptico |
| 1000 mg comp.x 30 | $160.958,55 | (31/03/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $79.365,99 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $47.995,01 AF $112.963,54 |
|
|
|
|
| 1000 mg comp.x 60 | $218.536,89 | (31/03/25) |
| Importado |
| PAMI |
|
| AF $85.926,18 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $76.507,27 AF $142.029,62 |
|
|
|
|
| 500 mg comp.x 20 | $67.140,63 | (31/03/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $29.636,24 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $29.990,26 AF $37.150,37 |
|
|
|
|
| 500 mg comp.x 30 | $76.549,19 | (31/03/25) |
| Importado |
| PAMI |
|
| AF $30.892,51 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $47.995,01 AF $28.554,18 |
|
|
|
|
| 500 mg comp.x 60 | $150.890,65 | (31/03/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $74.401,67 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $76.507,27 AF $74.383,38 |
|
|
|
|
| sol.oral x 300 ml | $201.068,44 | (31/03/25) |
| Importado |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $85.086,07 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $92.837,80 AF $108.230,64 |
|
|
|
|
| |
